JPRN-UMIN000019421已完成未知
Short term tapering of Ruxolitinib prior conditioning therapy with allogeneic stem cell transplantation for primary myelofibrosis - Short term tapering of Ruxolitinib prior allo-SCT for primary MF
Department of Internal Medicine, Hakodate Municipal Hospital, Hakodate, Japan0 个研究点目标入组 2 人开始时间: 2015年10月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 2
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Positive of HBs antigen, HCV antibody, HIV antibody or HTLV-1 antibody 2.Uncontrollable psychiatric symptom 3.Pregnant woman or lactating 4.Active other cancers 5.Uncontrollable active infection 6.Hepatic cirrhosis 7.More than BMI 35 8.Others
研究者
相似试验
招募中
1 期
Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-Guided Dose Reduction in Patients with Rheumatoid Arthritis: The RITUXERA Trial.MedDRA version: 21.0Level: PTClassification code: 10039073Term: Rheumatoid arthritis Class: 100000004859Rheumatoid arthritisCTIS2023-506638-59-01Z Leuven134
进行中（未招募）
1 期
Ruxolitinib therapy to Avoid Ventilation and improve outcome for deteriorating COVID-19 patientsEUCTR2020-001777-71-GBGuy’s and St Thomas' NHS Foundation Trust59
进行中（未招募）
不适用
Study with ruxolitinib to evaluate efficacy and safety in Patients with Proliferative Chronic Myelomonocytic LeukemiaProliferative Chronic Myelomonocytic Leukemia (CMML)MedDRA version: 16.1Level: LLTClassification code 10054350Term: Chronic myelomonocytic leukemiaSystem Organ Class: 100000004864EUCTR2013-004370-10-ESGrupo Español de Sindromes Mielodisplásicos (GESMD)
已完成
3 期
A5349TuberculosisPACTR202005623677468AIDS Clinical Trials Group54
进行中（未招募）
不适用
Clinical trial to shortening the treatment for pulmonary tuberculosis with rifapentin containing regimen.Pulmonary tuberculosisEUCTR2015-003446-45-ESnidad de investigación en Tuberculosis de Barcelona2,500